Industry: Service & Software
Published Date: 2024-04-22
Pages: 75 Pages
Report ld: 3037761
Request Sample
Customized Report
Soliris Intravenous, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS).
Market Analysis and Insights: Global Soliris Intravenous Market
The global Soliris Intravenous market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
In the last several years, Asia-Pacific market of Soliris Intravenous developed rapidly.Japan is the largest consumption place. Market competition is not intense.The FDA will not approve biosimilar applications for Soliris Intravenous before 16 March 2019; there is an ongoing debate over the length of exclusivity periods.
Report Covers:
This report presents an overview of global market for Soliris Intravenous market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Soliris Intravenous, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Soliris Intravenous, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Soliris Intravenous revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Soliris Intravenous market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Soliris Intravenous revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Alexion. etc.
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soliris Intravenous Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Plasma Exchange
1.2.3 Plasma Infusion
1.3 Market by Application
1.3.1 Global Soliris Intravenous Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 PNH
1.3.3 AHUS
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Soliris Intravenous Market Perspective (2019-2030)
2.2 Global Soliris Intravenous Growth Trends by Region
2.2.1 Soliris Intravenous Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Soliris Intravenous Historic Market Size by Region (2019-2024)
2.2.3 Soliris Intravenous Forecasted Market Size by Region (2025-2030)
2.3 Soliris Intravenous Market Dynamics
2.3.1 Soliris Intravenous Industry Trends
2.3.2 Soliris Intravenous Market Drivers
2.3.3 Soliris Intravenous Market Challenges
2.3.4 Soliris Intravenous Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Soliris Intravenous by Players
3.1.1 Global Soliris Intravenous Revenue by Players (2019-2024)
3.1.2 Global Soliris Intravenous Revenue Market Share by Players (2019-2024)
3.2 Global Soliris Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Soliris Intravenous, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Soliris Intravenous Market Concentration Ratio
3.4.1 Global Soliris Intravenous Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soliris Intravenous Revenue in 2023
3.5 Global Key Players of Soliris Intravenous Head office and Area Served
3.6 Global Key Players of Soliris Intravenous, Product and Application
3.7 Global Key Players of Soliris Intravenous, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Soliris Intravenous Breakdown Data by Type
4.1 Global Soliris Intravenous Historic Market Size by Type (2019-2024)
4.2 Global Soliris Intravenous Forecasted Market Size by Type (2025-2030)
5 Soliris Intravenous Breakdown Data by Application
5.1 Global Soliris Intravenous Historic Market Size by Application (2019-2024)
5.2 Global Soliris Intravenous Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Soliris Intravenous Market Size (2019-2030)
6.2 North America Soliris Intravenous Market Size by Type
6.2.1 North America Soliris Intravenous Market Size by Type (2019-2024)
6.2.2 North America Soliris Intravenous Market Size by Type (2025-2030)
6.2.3 North America Soliris Intravenous Market Share by Type (2019-2030)
6.3 North America Soliris Intravenous Market Size by Application
6.3.1 North America Soliris Intravenous Market Size by Application (2019-2024)
6.3.2 North America Soliris Intravenous Market Size by Application (2025-2030)
6.3.3 North America Soliris Intravenous Market Share by Application (2019-2030)
6.4 North America Soliris Intravenous Market Size by Country
6.4.1 North America Soliris Intravenous Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Soliris Intravenous Market Size by Country (2019-2024)
6.4.3 North America Soliris Intravenous Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Soliris Intravenous Market Size (2019-2030)
7.2 Europe Soliris Intravenous Market Size by Type
7.2.1 Europe Soliris Intravenous Market Size by Type (2019-2024)
7.2.2 Europe Soliris Intravenous Market Size by Type (2025-2030)
7.2.3 Europe Soliris Intravenous Market Share by Type (2019-2030)
7.3 Europe Soliris Intravenous Market Size by Application
7.3.1 Europe Soliris Intravenous Market Size by Application (2019-2024)
7.3.2 Europe Soliris Intravenous Market Size by Application (2025-2030)
7.3.3 Europe Soliris Intravenous Market Share by Application (2019-2030)
7.4 Europe Soliris Intravenous Market Size by Country
7.4.1 Europe Soliris Intravenous Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Soliris Intravenous Market Size by Country (2019-2024)
7.4.3 Europe Soliris Intravenous Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Soliris Intravenous Market Size (2019-2030)
8.2 China Soliris Intravenous Market Size by Type
8.2.1 China Soliris Intravenous Market Size by Type (2019-2024)
8.2.2 China Soliris Intravenous Market Size by Type (2025-2030)
8.2.3 China Soliris Intravenous Market Share by Type (2019-2030)
8.3 China Soliris Intravenous Market Size by Application
8.3.1 China Soliris Intravenous Market Size by Application (2019-2024)
8.3.2 China Soliris Intravenous Market Size by Application (2025-2030)
8.3.3 China Soliris Intravenous Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Soliris Intravenous Market Size (2019-2030)
9.2 Asia Soliris Intravenous Market Size by Type
9.2.1 Asia Soliris Intravenous Market Size by Type (2019-2024)
9.2.2 Asia Soliris Intravenous Market Size by Type (2025-2030)
9.2.3 Asia Soliris Intravenous Market Share by Type (2019-2030)
9.3 Asia Soliris Intravenous Market Size by Application
9.3.1 Asia Soliris Intravenous Market Size by Application (2019-2024)
9.3.2 Asia Soliris Intravenous Market Size by Application (2025-2030)
9.3.3 Asia Soliris Intravenous Market Share by Application (2019-2030)
9.4 Asia Soliris Intravenous Market Size by Region
9.4.1 Asia Soliris Intravenous Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Soliris Intravenous Market Size by Region (2019-2024)
9.4.3 Asia Soliris Intravenous Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Soliris Intravenous Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Soliris Intravenous Market Size by Type
10.2.1 Middle East, Africa, and Latin America Soliris Intravenous Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Soliris Intravenous Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Soliris Intravenous Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Soliris Intravenous Market Size by Application
10.3.1 Middle East, Africa, and Latin America Soliris Intravenous Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Soliris Intravenous Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Soliris Intravenous Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Soliris Intravenous Market Size by Country
10.4.1 Middle East, Africa, and Latin America Soliris Intravenous Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Soliris Intravenous Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Soliris Intravenous Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Alexion
11.1.1 Alexion Company Details
11.1.2 Alexion Business Overview
11.1.3 Alexion Soliris Intravenous Introduction
11.1.4 Alexion Revenue in Soliris Intravenous Business (2019-2024)
11.1.5 Alexion Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Soliris Intravenous was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 91
USD 3950.00
(Single User License)
The global Soliris Intravenous market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 94
USD 2900.00
(Single User License)
The global Soliris Intravenous market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 68
USD 4250.00
(Single User License)
The global market for Soliris Intravenous was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 76
USD 3950.00
(Single User License)
The global market for Soliris Intravenous was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-27
Pages: 66
USD 2900.00
(Single User License)
Soliris Intravenous, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS).
Published Date: 2024-01-24
Pages: 70
USD 3950.00
(Single User License)
Soliris Intravenous, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS).
Published Date: 2024-01-05
Pages: 62
USD 2900.00
(Single User License)
The global market for Soliris Intravenous was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 91
The global Soliris Intravenous market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 94
The global Soliris Intravenous market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 68
The global market for Soliris Intravenous was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 76
The global market for Soliris Intravenous was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-27
Pages: 66
Soliris Intravenous, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS).
Published: 2024-01-24
Pages: 70
Soliris Intravenous, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS).
Published: 2024-01-05
Pages: 62
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now